TITLE

Noteworthy

PUB. DATE
December 2008
SOURCE
Pharmaceutical Representative;Dec2008, Vol. 38 Issue 12, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents several studies related to health and medicine. The journal "Cancer Research" revealed that large doses of Vitamin C will reduce the therapeutic effects of chemotherapy drugs. The journal "Human Reproduction" presented that depression can result to pre-term delivery. The U.S. Center for Studying Health System Change showed that only 41% of adults are aware on health management.
ACCESSION #
35648936

 

Related Articles

  • Celgene Outlook Is Upbeat. Investor's Business Daily // Investors Business Daily;1/13/2015, pA01 

    2 The drug developer offered a bullish forecast for its cancer drug Revlimid along with positive preliminary Q4 results.

  • Epigenetic Determinants of Resistance to Etoposide Regulation of Bcl-x... and Bax by... Taylor, Sian T.; Hickman, John A. // JNCI: Journal of the National Cancer Institute;01/05/2000, Vol. 92 Issue 1, p18 

    Presents a study on the role of epigenetic factors, as well as genetic changes in surviving cancer cells, in drug resistance following cancer chemotherapy. Methodology; Results; Discussion.

  • Ringing the changes. Holmes, Andrew // Nature;12/11/1997, Vol. 390 Issue 6660, p560 

    Discusses research which described the compound eleutherobin's total synthesis and absolute stereochemistry. Eleutherobin and treatment of multiple drug resistance in cancer chemotherapy; Research by Nicolaou et al; Structural diversity of taxol mimics; Closure of medium-sized rings from...

  • A cancer therapy resistant to resistance. Kerbel, Robert S. // Nature;11/27/1997, Vol. 390 Issue 6658, p335 

    Discusses research which tested an inhibitor of angiogenesis called endostatin on three different mouse tumors. Research by Boehm et al in this issue; Limitations on effectiveness of cancer drugs; Acquired drug resistance; Instability of tumor cells; Basis of using angiogenesis to avoid...

  • Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Boehm, Thomas; Folkman, Judah // Nature;11/27/1997, Vol. 390 Issue 6658, p404 

    Presents research which studied the effects of the angiogenesis inhibitor endostatin on mice bearing Lewis lung carcinoma. Problem of acquired drug resistance; Cause of resistance; Stability of endothelial cells; Methods of study; Result of no development of drug resistance; Unexpected findings.

  • Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Kaufmann, Scott H; Vaux, David L // Oncogene;10/20/2003 Review 6, Vol. 22 Issue 47, p7414 

    Anticancer drugs can potentially kill cells in two fundamentally different ways, by interfering with cellular processes that are essential for maintenance of viability or by triggering an endogenous physiological cell death mechanism. Apoptosis is a form of physiological cell death mediated by...

  • Cancer Cell: Hutchinson Center scientists break through pancreas cancer treatment barrier.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article informs that researchers have found a barrier to the pancreas cancer treatment which prevented action of chemotherapy stems on tumors.

  • Cancer Cell: Hutchinson Center scientists break through pancreas cancer treatment barrier.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article focuses on a research by the organization Fred Hutchinson Cancer Research Center, in which researchers have found a way to break the biological barrier formed by pancreatic cancer tumors as a part of their resistance to chemotherapy stems.

  • Role of Alpha1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL (supra)+ Leukemic... Gambacorti-Passerini, Carlo; Barni, Rossella // JNCI: Journal of the National Cancer Institute;10/18/2000, Vol. 92 Issue 20, p1641 

    Describes the molecular characterization of a murine model for in vivo resistance to the antineoplastic drug STI571. Treatment of three groups of nude mice with STI571 beginning one day, eight days or 15 days after they were injected with human leukemic tumor cells; Evidence that alpha1 acid...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics